Abstract
Purpose
Although procalcitonin (PCT) has been described as a marker of infection and inflammation, it has not been extensively studied in patients with chronic kidney disease (CKD), end stage renal disease, or renal transplant.
Methods
PCT was routinely tested in 82 (56 dialyzed patients and 28 renal transplant recipients) consecutive cases with a strong clinical suspicion of infection, during a 6-month period, in a single referral unit.
Results
During the study period, 58/82 cases had confirmed infections as per definition. Patients with confirmed infections had higher values for PCT [median = 2.5 ng/mL, interquartile range (IR) = 0.9–5 ng/mL] than those without (median = 0.3 ng/mL, IR = 0.1–0.5 ng/mL), p < 0.001. Overall, for a cutoff value of 0.5 ng/mL, the sensitivity of the test was 93.1 % and the specificity 78.6.
Conclusion
Our data indicate that significantly elevated PCT concentrations offer good sensitivity and specificity for the early diagnosis of systemic bacterial infection in patients with CKD.
Similar content being viewed by others
References
Carrigan SD, Scott G, Tabrizian M (2004) Toward resolving the challenges of sepsis diagnosis. Clin Chem 50:1301–1314
Jaimes F, Arango C, Ruiz G et al (2004) Predicting bacteremia at the bedside. Clin Infect Dis 38:357–362
Bone RC, Balk RA, Cerra FB et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655
Reynvoet E, Vandijck DM, Blot SI et al (2009) Epidemiology of infection in critically ill patients with acute renal failure. Crit Care Med 37:2203–2209
Davenport A (2009) Peritonitis remains the major clinical complication of peritoneal dialysis. The London, UK, peritonitis audit 2002–2003. Perit Dial Int 29:297–302
Hildebrand A, Komenda P, Miller L et al (2010) Peritonitis and exit site infections in first nations patients on peritoneal dialysis. Clin J Am Soc Nephrol 5:1988–1995
James MT, Laupland KB, Tonelli M et al (2008) Risk of blood stream infectionin patients with chronic kidney disease not treated with dialysis. Arch Intern Med 168:2333–2339
James MT, Quan H, Tonelli M et al (2009) CKD and risk of hospitalization and death with pneumonia. Am J Kidney Dis 54:24–32
Lever A, Mackenzie I (2007) Sepsis: definition, epidemiology, and diagnosis. BMJ 335:879–883
Bossink A, Groeneveld J, Lambertus G (1999) Prediction of microbial infection and mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastase-alpha-antitrypsin and lactoferrin compared with clinical variables. Clin Infect Dis 29:398–407
Lu X-L, Xiao Z-H, Yang M-Y et al (2012) Diagnostic value of serum procalcitonin in patients with chronic renal insufficiency: a systematic review and meta-analysis. Nephrol Dial Transplant 28:122–129
Tang H, Huang T, Jing J et al (2009) Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis. Infection 37:497–507
Jones AE, Fiechtl JF, Brown MD et al (2007) Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med 50:34–41
Guz G, Colak B, Hizel K et al (2006) Procalcitonin and conventional markers of inflammation in peritoneal dialysis patients and peritonitis. Perit Dial Int 26:240–248
Simon L, Gauvin F, Amre DK et al (2004) Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39:206–217
Lam MF, Leung JC, Lam CW et al (2008) Procalcitonin fails to differentiate inflammatory status or predict long-term outcomes in peritoneal dialysis-associated peritonitis. Perit Dial Int 28:377–384
Öztürk R, Yilmaz GR, Bulut C et al (2010) Assessment of procalcitonin and other inflammatory markers in peritoneal dialysis-related peritonitis. Turk J Med Sci 40:199–206
Yilmaz FM, Yilmaz G, Akay H et al (2007) Evaluation of a card test for procalcitonin in continuous ambulatory peritoneal dialysis peritonitis. Ann Clin Biochem 44:482–484
Steinbach G, Bolke E, Grunert A et al (2004) Procalcitonin in patients with acute and chronic renal insufficiency. Wien Klin Wochenschr 116:849–853
Amour J, Birenbaum A, Langeron O et al (2008) Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery. Crit Care Med 36:1147–1154
Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med 29(4):530–538
Woodhead M, Blasi F, Ewig S et al (2011) Guidelines for the management of adult lower respiratory tract infections. Clin Microbiol Infect 17(Suppl 6):E1–E59
Gupta K, Hooton TM, Naber KG et al (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52(5):e103–e120
Farthing M, Salam M, Lindberg G et al (2012) World Gastroenterology Organisation global guidelines: Acute diarrhea in adults and children: a global perspective. Feb 2012. http://www.worldgastroenterology.org/assets/export/userfiles/Acute%20Diarrhea_long_FINAL_120604.pdf
ISPD Guidelines/Recommendations (2010) Peritoneal dialysis related infections recommendations: 2010 update. Perit Dial Int 30:393
Hanley JA, McNeil BJ (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148(3):839–843
Meisner M, Huttemann E, Lohs T et al (2000) Elimination of procalcitonin and plasma concentrations during continuous veno-venous haemodiafiltration in septic patients. Eur J Anaesthesiol 17:665–671
Meisner M, Hüttemann E, Lohs T et al (2001) Plasma concentrations and clearance of procalcitonin during continuous veno-venous hemofiltration in septic patients. Shock 15(3):171–175
Meisner M, Lohs T, Huettemann E et al (2001) The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function. Eur J Anaesthesiol 18:79–87
Eberhard OK, Langefeld I (1998) Procalcitonin in the early phase after renal transplantation—will it add to diagnostic accuracy? Clin Transpl 12(3):206–211
Hammer S, Meisner F, Dirschedl P et al (2000) Procalcitonin for differential diagnosis of graft rejection and infection in patients with heart and/or lung grafts. Intensive Care Med 26(2):S182–S186
Sabat R, Höflich C, Döcke WD et al (2001) Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies. Intensive Care Med 27(6):987–991
Cooper D, Sharples L, Cornelissen J et al (2001) Comparison between procalcitonin, serum amyloid A, and C-reactive protein as markers of serious bacterial and fungal infections after solid organ transplantation. Transpl Proc 33(1–2):1808–1810
Hedt BL, Pagano M (2011) Health indicators: eliminating bias from convenience sampling estimators. Stat Med 30(5):560–568
van den Broek MA, Olde Damink SW, Winkens B et al (2010) Procalcitonin as a prognostic marker for infectious complications in liver transplant recipients in an intensive care unit. Liver Transpl 16(3):402–410
Acknowledgments
This study was funded by the University of Medicine and Pharmacy, Iasi (grants numbers 1640/01.02.2013, 1641/01.02.2013 and IDEI—PCE 2011).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dumea, R., Siriopol, D., Hogas, S. et al. Procalcitonin: diagnostic value in systemic infections in chronic kidney disease or renal transplant patients. Int Urol Nephrol 46, 461–468 (2014). https://doi.org/10.1007/s11255-013-0542-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-013-0542-8